Kamada (KMDA) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $8.91
• Market Cap: $537.01M
• P/E Ratio: 26.60
• EPS: $0.35
• Dividend Yield: 0.03%
• 52-Week High: $9.35
• 52-Week Low: $5.54

Market Sentiment

Kamada currently has a Bullish sentiment score of 0.35.

About Kamada

Kamada Ltd. is a biopharmaceutical company based in Rehovot, Israel, specializing in the development and commercialization of plasma-derived protein therapies for rare diseases. The company has established a robust pipeline targeting significant unmet medical needs, leveraging its proprietary technology to yield high-quality therapeutic solutions. With a strong commitment to innovation and a strategic focus on advancing patient care, Kamada presents a compelling investment opportunity in the ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Kamada and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is KMDA's current dividend yield?

Kamada (KMDA) has a current dividend yield of 0.03%.

Does KMDA pay dividends?

Yes, Kamada pays dividends with a current yield of 0.03%.

What is KMDA's P/E ratio?

Kamada has a price-to-earnings (P/E) ratio of 26.60.

What is KMDA's market cap?

Kamada (KMDA) has a market capitalization of $537.01M with a current stock price of $8.91.